Asked by: Lord Wills (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government how many leg ulcer patients in England were in (1) higher and intermediate managerial, administrative, or professional occupations, (2) supervisory, clerical and junior managerial, administrative, or professional occupations, (3) skilled manual occupations, (4) semi-skilled and unskilled manual occupations, and (5) no occupation, in each of the last ten years.
Answered by Lord O'Shaughnessy
The requested information is not centrally held by the Department. NHS Digital does not routinely collect any socio-economic or occupation-related data in association with patient episodes.
Asked by: Lord Wills (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government how many leg ulcer patients in England were aged (1) 18 to 39 years, (2) 40 to 59 years, and (3) 60 years or older, in each of the last ten years.
Answered by Lord O'Shaughnessy
The information is not available in the format requested.
Asked by: Lord Wills (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government how many leg ulcer patients in England were (1) male, and (2) female, in each of the last ten years.
Answered by Lord O'Shaughnessy
The information is not available in the format requested.
Asked by: Lord Wills (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what assessment they have made of the number of people in England suffering from leg ulcers in England in each of the last 10 years.
Answered by Lord O'Shaughnessy
The information is not available in the format requested.
Asked by: Lord Wills (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what assessment they have made of the annual cost to the NHS in England of leg ulcer patients undergoing superficial venous reflux treatment.
Answered by Lord O'Shaughnessy
No such assessment has been made as the relevant data is not held centrally by the Department.
Asked by: Lord Wills (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what assessment they have made of the cost to the NHS in England of leg ulcers in each of the last 10 years.
Answered by Lord O'Shaughnessy
No such assessment has been made as the relevant data is not centrally held by the Department.
Asked by: Lord Wills (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what assessment they have made of the benefits to the NHS in England of early endovenous ablation of leg ulcers.
Answered by Lord O'Shaughnessy
The results of the Early Venous Reflux Ablation (EVRA) study (2018) and the Effect of Surgery and Compression on Healing and Recurrence (ESCHAR) trial (2004) indicate that early superficial endovenous ablation improves healing of venous leg ulceration, reduces the risk of ulcer recurrence and is cost-effective.
Therefore, the results of the EVRA study and the ESCHAR trial will be incorporated into the National Wound Care Strategy Programme recommendations for care, as this will bring benefits to both patients and the National Health Service.
Asked by: Lord Wills (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what assessment they have made of the efficacy of patient leg ulcer care pathways developed by the Venous Forum of the Royal Society of Medicine.
Answered by Lord O'Shaughnessy
NHS England is not aware of any assessments of the efficacy of patient leg ulcer care pathways developed by the Venous Forum of the Royal Society of Medicine.
There are plans to develop a national patient leg ulcer care pathway, and the Venous Forum has been invited to join the lower limb workstream to contribute to the development of this pathway.
Asked by: Lord Wills (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what assessment they have made of the benefits to people aged over 65 of endovenous ablation treatment of varicose veins.
Answered by Lord O'Shaughnessy
Varicose veins can cause complications because they stop blood flowing properly, including venous leg ulcers as a result of chronic venous insufficiency.
The results of the Early Venous Reflux Ablation (EVRA) study (2018) and the Effect of Surgery and Compression on Healing and Recurrence (ESCHAR) trial (2004) indicate that early superficial endovenous ablation improves healing of venous leg ulceration, reduces the risk of ulcer recurrence and is cost-effective.
Therefore, the results of the EVRA study and the ESCHAR trial will be incorporated into the National Wound Care Strategy Programme recommendations for care, as this will bring benefits to both patients and the National Health Service.
The EVRA study and the ESCHAR trial included patients over the age of 65 so the results are applicable to older people. However, no sub-analysis is presented for people over the age of 65 so it is not possible to identify if there are any benefits or risks beyond the overall results for people over 65.
Asked by: Lord Wills (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government, further to the Written Answer by Lord O’Shaughnessy on 5 April (HL6371), whether they have made any estimate of the cost of mesothelioma to the NHS; and if so, what.
Answered by Lord O'Shaughnessy
Neither the Department or its arm’s length bodies have made any formal assessment or estimate about the cost of mesothelioma to the National Health Service.